We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including cl... read more Featured Products: More products

Download Mobile App




Intermittently Scanned CGM Positively Impacts Glycemic Control in Diabetics

By HospiMedica International staff writers
Posted on 13 Jan 2020
Print article
Image: The Freestyle Libre isCGM monitor (Photo courtesy of Abbot)
Image: The Freestyle Libre isCGM monitor (Photo courtesy of Abbot)
People with type 1 diabetes (T1D) who use intermittently scanned continuous glucose monitoring (isCGM) devices report higher treatment satisfaction, quality of life (QOL), and less severe hypoglycemia, according to a new study.

Researchers at Katholieke Universiteit Leuven (KU; Belgium), the University of Antwerp (Belgium), and other institutions conducted a 12-month prospective observational study to investigate the impact of isCGM on QOL and glycemic control in 1,913 adults with T1D who were consecutively recruited in three specialist diabetes centers in Belgium. The primary end point was evolution of QOL from baseline to 12 months, with secondary outcomes including change in hemoglobin A1C (HbA1c), time spent in different glycemic ranges, acute diabetes complications, and work absenteeism.

The results showed that HbA1c levels remained stable, as did the participants general and diabetes-specific QOL; treatment satisfaction improved during the study period. While rare, admissions for severe hypoglycemia and/or ketoacidosis decreased, reports of severe hypoglycemic events fell (14.6% versus 7.8%), as did hypoglycemic comas (2.7% versus 1.1%). Absences from work fell by 50%, but 11% of study participants experienced adverse skin reactions, leading to about one percent stopping isCGM. The study was published on December 24, 2019, in Diabetes Care.

“In 2016, nationwide reimbursement of intermittently scanned continuous glucose monitoring for people living with type one diabetes treated in specialist diabetes centers was introduced in Belgium,” concluded lead author Sara Charleer, MSc, of KU, and colleagues. “Unrestricted reimbursement results in higher treatment satisfaction, less severe hypoglycemia, and less work absenteeism, while maintaining quality of life and HbA1c.”

The isCGM device used for the study was the Abbott (Abbott Park, IL, USA) Freestyle Libre system, which continuously samples and measures interstitial glucose levels; a new glucose value is generated each minute. The sensor can provide glucose values for 14 days if the patient scans at least every 8 hours. If not, the glucose information from the previous 8-hour period will be overwritten and will not available for therapy decision-making or for later download. Unlike real time CGM devices, the Libre is factory-calibrated, which eliminates the need for daily calibration with fingerstick testing.

Related Links:
Katholieke Universiteit Leuven
University of Antwerp
Abbott


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Surgial Headlight
MedLED Chrome

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.